The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Lentiviral Gene Therapy for Artemis-Deficient SCID
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In 2022, they reported that five of six treated ART SCID patients followed for 24 or more months had T cell immune reconstitution, at a median of 12 months, with other manifestations of T and B cell immunity.”
From Ex vivo modification of hematopoietic stem and progenitor cells for gene therapy (2025) · cites this paper as [33]
In the citing paper
“Four patients who were followed for at least 24 months had sufficient B cell function to permit the discontinuation of immunoglobulin infusions.”
From Ex vivo modification of hematopoietic stem and progenitor cells for gene therapy (2025) · cites this paper as [33]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lentiviral Gene Therapy Combined with Low-Dose Busulfan in Infants with SCID-X1
Mamcarz, E., Zhou, S., Lockey, T., Abdelsamed, H., Cross, S. J., Kang, G., Ma, Z., Condori, J., Dowdy, J., Triplett, B., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1815408 · Cited by 263
Self-citation
Research works printed but not linked: 32
- 10.1016/j.jaci.2013.09.044 · DOI
- 10.1016/j.jaci.2018.08.027 · DOI
- 10.1001/jama.2014.9132 · DOI
- 10.1542/peds.2018-2300 · DOI
- 10.4049/jimmunol.168.12.6323 · DOI
- 10.1016/j.iac.2009.10.004 · DOI
- 10.1182/blood-2018-03-840702 · DOI
- 10.1016/j.dnarep.2005.02.001 · DOI
- 10.1038/sj.bmt.1702831 · DOI
- 10.1182/blood-2013-01-476432 · DOI
- 10.1056/NEJMoa2027675 · DOI · Paper page
- 10.3389/fimmu.2020.608653 · DOI
- 10.1126/scitranslmed.aad8856 · DOI · Paper page
- 10.1089/hum.2016.064 · DOI
- 10.1073/pnas.0608130103 · DOI
- 10.1089/hum.2009.162 · DOI
- 10.1089/dna.2011.1244 · DOI
- 10.1016/j.bbmt.2013.08.014 · DOI
- 10.1038/sj.emboj.7600206 · DOI · Paper page
- 10.1002/humu.21168 · DOI
- 10.1001/archderm.135.8.927 · DOI
- 10.1155/2015/352934 · DOI
- 10.1126/sciimmunol.abi7160 · DOI
- 10.1137/1104033 · DOI
- 10.1038/mt.2011.20 · DOI
- 10.1038/mt.2009.16 · DOI
- 10.1182/blood-2010-09-306761 · DOI · Paper page
- 10.1089/hum.2014.062 · DOI
- 10.1016/j.bbmt.2007.03.009 · DOI
- 10.1182/bloodadvances.2019000298 · DOI
- 10.1038/sj.bmt.1702011 · DOI
- 10.1016/j.bbmt.2017.12.782 · DOI
Cited by
Ex vivo modification of hematopoietic stem and progenitor cells for gene therapy
Williams, D. A., Kohn, D. B., & Thrasher, A. J. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.03.058 · Cited by 11
Metadata
- Authors
- Cowan, M. J., Yu, J., Facchino, J., Fraser-Browne, C., Sanford, U., Kawahara, M., Dara, J., Long-Boyle, J., Oh, J., Chan, W., Chag, S., Broderick, L., Chellapandian, D., Decaluwe, H., Golski, C., Hu, D., Kuo, C. Y., Miller, H. K., Petrovic, A., Currier, R., Hilton, J. F., Punwani, D., Dvorak, C. C., Malech, H. L., McIvor, R. S., & Puck, J. M.
- Affiliations
- From the Departments of Pediatrics (M.J.C., J.Y., J.F., C.F.-B., U.S., M.K., J.D., J.L.-B., W.C., S.C., R.C., C.C.D., J.M.P.) and Epidemiology and Biostatistics (J.F.H.), the Smith Cardiovascular Research Institute (M.J.C., J.M.P.), and the School of Pharmacy (J.L.-B.), University of California, San Francisco (UCSF), and UCSF Benioff Children’s Hospital (M.J.C., J.F., J.D., J.L.-B., J.O., C.C.D., J.M.P.), San Francisco, the Department of Pediatrics, University of California, San Diego, and Rady Children’s Hospital, San Diego (L.B.), and the Department of Pediatrics, UCLA Mattel Children’s Hospital, Los Angeles (C.Y.K.) — all in California; the Department of Pediatrics, Johns Hopkins All Children’s Hospital, St. Petersburg, FL (D.C.); the Department of Pediatrics, Sainte-Justine University Hospital Center, University of Montreal, Montreal (H.D.); Tuba City Regional Health Care, Tuba City (C.G., D.H.), and Phoenix Children’s Hospital, Phoenix (H.K.M.) — both in Arizona; the Department of Pediatrics, Universi...
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2022-12-22
- Volume
- 387
- Issue
- 25
- Pages
- 2344-2355
- ISSN
- 0028-4793
- 1533-4406
- PMC
- PMC9884487
- Cited by
- 79
- References
- 1
- Language
- en
- Funders
- California Institute for Regenerative Medicine (CLIN2-10830)
- National Institute of Allergy and Infectious Diseases (U54-AI082973)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lentiviral Gene Therapy for Artemis-Deficient SCID. https://app.cochat.ai/papers/10.1056/nejmoa2206575
- The paper
- Cowan, M. J., Yu, J., Facchino, J., Fraser-Browne, C., Sanford, U., Kawahara, M., Dara, J., Long-Boyle, J., Oh, J., Chan, W., Chag, S., Broderick, L., Chellapandian, D., Decaluwe, H., Golski, C., Hu, D., Kuo, C. Y., Miller, H. K., Petrovic, A., . . . Puck, J. M. (2022). Lentiviral Gene Therapy for Artemis-Deficient SCID. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2206575